Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study

Background:. To determine the superiority of autologous abdominal tissue (AAT) or tissue-expander implant (TE/I) reconstruction, a robust comparative cohort study is required. This study sought to determine the feasibility of a future large pragmatic cohort study comparing clinical and cost-effectiv...

Full description

Bibliographic Details
Main Authors: Achilles Thoma, MD, MSc, Ronen Avram, MD, MSc, Arianna Dal Cin, MD, MBA, Jessica Murphy, MSc, PhD(c), Eric Duku, PhD, Feng Xie, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2020-10-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003179
id doaj-34e3f22fbe224090bc016cd56cefd962
record_format Article
spelling doaj-34e3f22fbe224090bc016cd56cefd9622020-12-23T08:14:28ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742020-10-01810e317910.1097/GOX.0000000000003179202010000-00005Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility StudyAchilles Thoma, MD, MSc0Ronen Avram, MD, MSc1Arianna Dal Cin, MD, MBA2Jessica Murphy, MSc, PhD(c)3Eric Duku, PhD4Feng Xie, PhD5From the * Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, Ontario;From the * Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, Ontario;From the * Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, Ontario;From the * Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, Ontario;‡ Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario;† Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario;Background:. To determine the superiority of autologous abdominal tissue (AAT) or tissue-expander implant (TE/I) reconstruction, a robust comparative cohort study is required. This study sought to determine the feasibility of a future large pragmatic cohort study comparing clinical and cost-effectiveness of AAT and TE/I at 12 months postoperative. Methods:. Potential participants were screened during consultation with their surgeon. Three health-related quality-of-life scales, the Health Utility Index Mark 3, the 12-Item Short Form Health Survey, and the BREAST-Q were used preoperatively, 1, 6, and 12 months postoperatively. Direct medical costs and postoperative patient/caregiver productivity loss were collected using patient diaries. Feasibility was assessed through patient recruitment rates and compliance of patients and study staff to complete required study documentation. Results:. Sixty-three patients consented to participate, 44 completed baseline questionnaires; the feasibility objective of recruiting 80% of eligible patients was not met. A 90% completion rate for patient questionnaires was seen at 1-month follow-up and decreased up to 12 months. Quality-adjusted life years were calculated at 0.77 and 0.89 for the AAT and TE/I group, respectively. Case report form completion by study staff and patient diary completion was moderate and low, respectively. Collaborating with hospital case-costing specialists to identify direct medical costs was reliable and efficient. Conclusions:. A future large-scale study is feasible. However, due to a diminishing rate of questionnaire completion, almost twice as many patients need to be recruited than expected to have adequate power. Cost data collection from hospital sources was reliable. Case report forms need to be tailored more toward a busy hospital setting.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003179
collection DOAJ
language English
format Article
sources DOAJ
author Achilles Thoma, MD, MSc
Ronen Avram, MD, MSc
Arianna Dal Cin, MD, MBA
Jessica Murphy, MSc, PhD(c)
Eric Duku, PhD
Feng Xie, PhD
spellingShingle Achilles Thoma, MD, MSc
Ronen Avram, MD, MSc
Arianna Dal Cin, MD, MBA
Jessica Murphy, MSc, PhD(c)
Eric Duku, PhD
Feng Xie, PhD
Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
Plastic and Reconstructive Surgery, Global Open
author_facet Achilles Thoma, MD, MSc
Ronen Avram, MD, MSc
Arianna Dal Cin, MD, MBA
Jessica Murphy, MSc, PhD(c)
Eric Duku, PhD
Feng Xie, PhD
author_sort Achilles Thoma, MD, MSc
title Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
title_short Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
title_full Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
title_fullStr Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
title_full_unstemmed Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study
title_sort comparing the clinical and cost-effectiveness of abdominal-based autogenous tissue and tissue-expander implant: a feasibility study
publisher Wolters Kluwer
series Plastic and Reconstructive Surgery, Global Open
issn 2169-7574
publishDate 2020-10-01
description Background:. To determine the superiority of autologous abdominal tissue (AAT) or tissue-expander implant (TE/I) reconstruction, a robust comparative cohort study is required. This study sought to determine the feasibility of a future large pragmatic cohort study comparing clinical and cost-effectiveness of AAT and TE/I at 12 months postoperative. Methods:. Potential participants were screened during consultation with their surgeon. Three health-related quality-of-life scales, the Health Utility Index Mark 3, the 12-Item Short Form Health Survey, and the BREAST-Q were used preoperatively, 1, 6, and 12 months postoperatively. Direct medical costs and postoperative patient/caregiver productivity loss were collected using patient diaries. Feasibility was assessed through patient recruitment rates and compliance of patients and study staff to complete required study documentation. Results:. Sixty-three patients consented to participate, 44 completed baseline questionnaires; the feasibility objective of recruiting 80% of eligible patients was not met. A 90% completion rate for patient questionnaires was seen at 1-month follow-up and decreased up to 12 months. Quality-adjusted life years were calculated at 0.77 and 0.89 for the AAT and TE/I group, respectively. Case report form completion by study staff and patient diary completion was moderate and low, respectively. Collaborating with hospital case-costing specialists to identify direct medical costs was reliable and efficient. Conclusions:. A future large-scale study is feasible. However, due to a diminishing rate of questionnaire completion, almost twice as many patients need to be recruited than expected to have adequate power. Cost data collection from hospital sources was reliable. Case report forms need to be tailored more toward a busy hospital setting.
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003179
work_keys_str_mv AT achillesthomamdmsc comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
AT ronenavrammdmsc comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
AT ariannadalcinmdmba comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
AT jessicamurphymscphdc comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
AT ericdukuphd comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
AT fengxiephd comparingtheclinicalandcosteffectivenessofabdominalbasedautogenoustissueandtissueexpanderimplantafeasibilitystudy
_version_ 1724372877434683392